Time-Varying Data Boosts Transplant Risk Accuracy 04/14/26
Welcome to Cardiology Today – Recorded April 14, 2026. This episode summarizes 5 key cardiology studies on topics like aspirin and left bundle branch block. Key takeaway: Time-Varying Data Boosts Transplant Risk Accuracy.
Article Links:
Article 1: Endovascular Therapy for Post-Thrombotic Syndrome – A Randomized Trial. (The New England journal of medicine)
Article 2: Cell Type-Specific Targeting of Different Smooth Muscle Cell Populations by Intersectional Genetics. (Circulation)
Article 3: Timing is everything: Using time-varying binary indicators for evaluating post-transplant risk factors. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation)
Article 4: Subclinical atrial fibrillation and the risk of heart failure: insights from ARTESiA. (European journal of heart failure)
Article 5: Dyssynchronous heart failure: mitochondrial distribution and functions mirror regional workload and energy demand in a large-animal model of ventricular desynchronization. (European journal of heart failure)
Full episode page: https://podcast.explainheart.com/podcast/time-varying-data-boosts-transplant-risk-accuracy-04-14-26/
📚 Featured Articles
Article 1: Endovascular Therapy for Post-Thrombotic Syndrome – A Randomized Trial.
Journal: The New England journal of medicine
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41972998
Summary: This randomized trial evaluated endovascular therapy, specifically iliac-vein stent placement, for patients with moderate or severe post-thrombotic syndrome linked to iliac-vein obstruction. The study included 225 patients who received either endovascular therapy or enhanced conventional management, addressing the critical clinical issue of improving quality of life. This trial focused on whether the intervention reduced symptom severity for patients severely affected by post-thrombotic syndrome.
Article 2: Cell Type-Specific Targeting of Different Smooth Muscle Cell Populations by Intersectional Genetics.
Journal: Circulation
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41969103
Summary: This study developed a new strategy using intersectional genetics for cell type-specific targeting of smooth muscle cell populations. This refined approach effectively overcomes limitations of existing Cre/loxP recombination systems that previously showed off-target activity outside the smooth muscle cell lineage. The new method precisely distinguishes among arterial smooth muscle cells, venous smooth muscle cells, and non-vascular smooth muscle cells. This capability is essential for characterizing the distinct roles of smooth muscle cells in various organs and diseases.
Article 3: Timing is everything: Using time-varying binary indicators for evaluating post-transplant risk factors.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41974389
Summary: This study demonstrated that incorporating a time-varying binary indicator in a Cox model correctly analyzes post-transplant risk factors. Traditional methods, which treat risk factors as fixed at the time of transplantation, produce inaccurate effect estimates due to immortal time bias. Using infection-related hospitalizations after heart transplantation as an example, this refined approach properly aligns the timing of exposure with survival follow-up. This methodology yields more credible and accurate effect estimates for risk factors emerging after transplantation.
Article 4: Subclinical atrial fibrillation and the risk of heart failure: insights from ARTESiA.
Journal: European journal of heart failure
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41973801
Summary: The ARTESiA (Apixaban for the Reduction of Thromboembolism in Patients with Device-Detected Subclinical Atrial Fibrillation) trial, involving 3986 patients, compared apixaban with aspirin for reducing thromboembolism in individuals with device-detected subclinical atrial fibrillation. This study leveraged the ARTESiA patient cohort to investigate the connection between subclinical atrial fibrillation and the incidence of heart failure events. It established that while heart failure and clinical atrial fibrillation are closely related, the specific impact of device-detected subclinical atrial fibrillation on heart failure risk remained previously undefined. The research therefore identified a critical area for further clinical understanding regarding this patient population.
Article 5: Dyssynchronous heart failure: mitochondrial distribution and functions mirror regional workload and energy demand in a large-animal model of ventricular desynchronization.
Journal: European journal of heart failure
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41968761
Summary: This study in an ovine model of dyssynchronous heart failure with left bundle branch block demonstrated that mitochondrial distribution and functions mirror regional workload and energy demand. Researchers established left bundle branch block-like activation in 11 sheep, observing them over eight weeks, alongside six control animals. The findings showed inhomogeneous left ventricular workload and systolic dysfunction in the dyssynchronous heart failure group. This research specifically linked metabolic remodeling, including glucose metabolism assessed by 18F-fluorodeoxyglucose tracers, to regional energetic stress in the diseased myocardium.
📝 Transcript
Today’s date is April 14, 2026. Welcome to Cardiology Today. Here are the latest research findings.
Article number one. Endovascular Therapy for Post-Thrombotic Syndrome – A Randomized Trial. This randomized trial evaluated endovascular therapy, specifically iliac-vein stent placement, for patients with moderate or severe post-thrombotic syndrome linked to iliac-vein obstruction. The study included 225 patients who received either endovascular therapy or enhanced conventional management, addressing the critical clinical issue of improving quality of life. This trial focused on whether the intervention reduced symptom severity for patients severely affected by post-thrombotic syndrome.
Article number two. Cell Type-Specific Targeting of Different Smooth Muscle Cell Populations by Intersectional Genetics. This study developed a new strategy using intersectional genetics for cell type-specific targeting of smooth muscle cell populations. This refined approach effectively overcomes limitations of existing Cre/loxP recombination systems that previously showed off-target activity outside the smooth muscle cell lineage. The new method precisely distinguishes among arterial smooth muscle cells, venous smooth muscle cells, and non-vascular smooth muscle cells. This capability is essential for characterizing the distinct roles of smooth muscle cells in various organs and diseases.
Article number three. Timing is everything: Using time-varying binary indicators for evaluating post-transplant risk factors. This study demonstrated that incorporating a time-varying binary indicator in a Cox model correctly analyzes post-transplant risk factors. Traditional methods, which treat risk factors as fixed at the time of transplantation, produce inaccurate effect estimates due to immortal time bias. Using infection-related hospitalizations after heart transplantation as an example, this refined approach properly aligns the timing of exposure with survival follow-up. This methodology yields more credible and accurate effect estimates for risk factors emerging after transplantation.
Article number four. Subclinical atrial fibrillation and the risk of heart failure: insights from ARTESiA. The ARTESiA (Apixaban for the Reduction of Thromboembolism in Patients with Device-Detected Subclinical Atrial Fibrillation) trial, involving 3986 patients, compared apixaban with aspirin for reducing thromboembolism in individuals with device-detected subclinical atrial fibrillation. This study leveraged the ARTESiA patient cohort to investigate the connection between subclinical atrial fibrillation and the incidence of heart failure events. It established that while heart failure and clinical atrial fibrillation are closely related, the specific impact of device-detected subclinical atrial fibrillation on heart failure risk remained previously undefined. The research therefore identified a critical area for further clinical understanding regarding this patient population.
Article number five. Dyssynchronous heart failure: mitochondrial distribution and functions mirror regional workload and energy demand in a large-animal model of ventricular desynchronization. This study in an ovine model of dyssynchronous heart failure with left bundle branch block demonstrated that mitochondrial distribution and functions mirror regional workload and energy demand. Researchers established left bundle branch block-like activation in 11 sheep, observing them over eight weeks, alongside six control animals. The findings showed inhomogeneous left ventricular workload and systolic dysfunction in the dyssynchronous heart failure group. This research specifically linked metabolic remodeling, including glucose metabolism assessed by 18F-fluorodeoxyglucose tracers, to regional energetic stress in the diseased myocardium.
Thank you for listening. Don’t forget to subscribe.
🔍 Keywords
aspirin, left bundle branch block, cell targeting, mitochondrial function, Cox model, endovascular therapy, iliac-vein stent, dyssynchronous heart failure, heart failure, smooth muscle cells, deep-vein thrombosis, myocardial remodeling, arterial smooth muscle cells, subclinical atrial fibrillation, heart transplantation, immortal time bias, ventricular desynchronization, risk factors, time-varying binary indicator, venous obstruction, post-thrombotic syndrome, ARTESiA trial, Cre-loxP system, apixaban, intersectional genetics, thromboembolism.
ℹ️ About
Concise summaries of cardiovascular research for professionals.
Subscribe • Share • Follow